And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is especially modest. We plan to catch up on our reading and napping, and supervise the exploits of our shortest person in a driving machine. And what about you? Various holidays are approaching, so this may be a good time to schedule a getaway or undertake a shopping spree in search of items for special someones (and boost the economy at the same time). Or you could brush up on your geography and measure just how small oceans may really be. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

In an unusual move, a federal judge on Thursday raised the prospect of not approving CVS Health’s (CVS) $69 billion deal to buy Aetna (AET), which closed earlier this week, Reuters writes. Judge Richard Leon of the U.S. District Court for the District of Columbia objected to what he said was his treatment by the government and the companies as a “rubber stamp” for the deal, noting that CVS had closed its deal on Wednesday. Leon raised the prospect of not deciding on the deal until the summer, or perhaps rejecting it, before setting another hearing for Monday.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy